Literature DB >> 25650273

Novel biophysical determination of miRNAs related to prostate and head and neck cancers.

Kristyna Hudcova1, Libuse Trnkova, Iva Kejnovska, Michaela Vorlickova, Jaromir Gumulec, Rene Kizek, Michal Masarik.   

Abstract

In this study we have chosen a new approach and characterized three miRNAs (miR-23a, miR-34a and miR-320a) related to prostate cancer and head and neck cancer by spectral (circular dichroic and UV-absorption spectra) and electrochemical (voltammetry at graphite and mercury electrodes) methods. The spectral and voltammetric results, reflecting different nucleotide sequences of miRNAs, were complemented by the results of DNAs(U) having the same oligonucleotide sequences as miRNAs. The effect of the substitution of ribose for deoxyribose was shown and structural diversity was confirmed. The stability of RNA and DNA(U) was studied using CD and UV-absorption spectroscopy and melting points were calculated. MiRNA-320a with the highest content of guanine provided the highest melting point. With respect to the rapid progress of miRNA electrochemical sensors, our results will be useful for the research and development of sensitive, portable and time-efficient miRNA sensors, which will be able to diagnose cancer and other diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25650273     DOI: 10.1007/s00249-015-1008-y

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  32 in total

1.  Label-free SERS detection of microRNA based on affinity for an unmodified silver nanorod array substrate.

Authors:  Jeremy D Driskell; Ralph A Tripp
Journal:  Chem Commun (Camb)       Date:  2010-03-24       Impact factor: 6.222

2.  Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs.

Authors:  Christopher K Raymond; Brian S Roberts; Phillip Garrett-Engele; Lee P Lim; Jason M Johnson
Journal:  RNA       Date:  2005-11       Impact factor: 4.942

Review 3.  MicroRNAs: key players in carcinogenesis and novel therapeutic targets.

Authors:  A H F Mirnezami; K Pickard; L Zhang; J N Primrose; G Packham
Journal:  Eur J Surg Oncol       Date:  2008-07-21       Impact factor: 4.424

Review 4.  Global epidemiology of oral and oropharyngeal cancer.

Authors:  Saman Warnakulasuriya
Journal:  Oral Oncol       Date:  2008-09-18       Impact factor: 5.337

5.  Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells.

Authors:  Samik Chakraborty; Minakshi Mazumdar; Shravanti Mukherjee; Pushpak Bhattacharjee; Arghya Adhikary; Argha Manna; Sreeparna Chakraborty; Poulami Khan; Aparna Sen; Tanya Das
Journal:  FEBS Lett       Date:  2014-01-18       Impact factor: 4.124

6.  MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression.

Authors:  L Scapoli; A Palmieri; L Lo Muzio; F Pezzetti; C Rubini; A Girardi; F Farinella; M Mazzotta; F Carinci
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Oct-Dec       Impact factor: 3.219

7.  Electrochemical detection of miRNA-222 by use of a magnetic bead-based bioassay.

Authors:  Francesca Bettazzi; Ezat Hamid-Asl; Carla Lucia Esposito; Cristina Quintavalle; Nello Formisano; Serena Laschi; Silvia Catuogno; Margherita Iaboni; Giovanna Marrazza; Marco Mascini; Laura Cerchia; Vittorio De Franciscis; Gerolama Condorelli; Ilaria Palchetti
Journal:  Anal Bioanal Chem       Date:  2012-10-26       Impact factor: 4.142

8.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

9.  Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.

Authors:  Bhavna Kumar; Arti Yadav; James Lang; Theodoros N Teknos; Pawan Kumar
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

10.  Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies.

Authors:  Michael D Mattie; Christopher C Benz; Jessica Bowers; Kelly Sensinger; Linda Wong; Gary K Scott; Vita Fedele; David Ginzinger; Robert Getts; Chris Haqq
Journal:  Mol Cancer       Date:  2006-06-19       Impact factor: 27.401

View more
  2 in total

1.  Long Non-Coding RNA GAS5 Suppresses Tumor Progression and Enhances the Radiosensitivity of Prostate Cancer Through the miR-320a/RAB21 Axis.

Authors:  Xiulong Ma; Zhongwei Wang; Hongtao Ren; Xing Bao; Yang Zhang; Baofeng Wang; Dongli Ruan
Journal:  Cancer Manag Res       Date:  2020-09-22       Impact factor: 3.989

2.  Low Expression of Mir-137 Predicts Poor Prognosis in Cutaneous Melanoma Patients.

Authors:  Nan Li
Journal:  Med Sci Monit       Date:  2016-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.